Full Year 2021 Valneva SE Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Valneva Presents its Audited Full Year 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to our first speaker today, Thomas Lingelbach. Please go ahead.
Welcome, and good day to our quarter 1 analyst call where we will report our full year 2021 results and provide corporate updates. So if you move to the Slide 2, please and acknowledge the disclaimer.
We go on to Slide 4 of the presentation. Yes, 2021 has been an exceptional year for Valneva. And we have been able to make excellent progress in all of our clinical programs. For Lyme disease, we reported further positive Phase II results, including booster data. We determined finally the final Phase III dose and vaccination schedule.
For our COVID-19 vaccine, we reported positive Phase III results, obtained a first emergency
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |